Johnson & Johnson Current Liabilities
The Current Liabilities of Johnson & Johnson (JNJ) as of Oct 18, 2026 is 54.13 B USD. In the previous year, Current Liabilities was 50.32 B USD — a change of 7.56% (higher).
Get this data via API
Financial Data API
Current Liabilities
54.13 BUSD
YoY
7.56%
Last updated:
The Johnson & Johnson Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 54.13 BUSD | +7.56% | |
| 50.32 BUSD | -32.87% | |
| 74.96 BUSD | +34.34% | |
| 55.80 BUSD | +23.38% | |
| 45.23 BUSD | +6.43% | |
| 42.49 BUSD | +18.15% | |
| 35.96 BUSD | +15.16% | |
| 31.23 BUSD | -37.61% | |
| 50.06 BUSD | +90.42% | |
| 26.29 BUSD | -5.26% | |
| 27.75 BUSD | +10.61% | |
| 25.09 BUSD | -2.30% | |
| 25.68 BUSD | +5.82% | |
| 24.26 BUSD | +6.36% | |
| 22.81 BUSD | -1.13% | |
| 23.07 BUSD | +6.17% | |
| 21.73 BUSD | +4.22% | |
| 20.85 BUSD | +5.12% | |
| 19.84 BUSD | -37.83% | |
| 31.91 BUSD | +152.53% | |
| 12.64 BUSD | -9.28% | |
| 13.93 BUSD | +3.56% | |
| 13.45 BUSD | +17.46% | |
| 11.45 BUSD | -9.94% | |
| 12.71 BUSD | +5.36% | |
| 12.07 BUSD | +58.99% | |
| 7.59 BUSD | -9.89% | |
| 8.42 BUSD | +56.31% | |
| 5.39 BUSD | +2.61% | |
| 5.25 BUSD | -24.45% | |
| 6.95 BUSD | +60.81% | |
| 4.32 BUSD | +23.56% | |
| 3.50 BUSD | +0.92% | |
| 3.47 BUSD | +27.90% | |
| 2.71 BUSD | -37.87% | |
| 4.36 BUSD | +39.32% | |
| 3.13 BUSD | +3.85% | |
| 3.02 BUSD | +15.21% | |
| 2.62 BUSD | -31.29% | |
| 3.81 BUSD | +119.74% | |
| 1.73 BUSD | +65.39% | |
| 1.05 BUSD | +12.45% | |
| 932.00 MUSD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Johnson & Johnson Stock analysis
Frequently Asked Questions about Johnson & Johnson stock
Current Liabilities of Johnson & Johnson is 54.13 B USD in 2025.
Current Liabilities of Johnson & Johnson changed from 50.32 B USD to 54.13 B USD, representing a 7.56% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Johnson & Johnson since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Johnson & Johnson historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Johnson & Johnson
All Key Metrics — Johnson & Johnson
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth